Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2007
11/15/2007WO2007111940A3 Regimens for immunisation with meningococcal conjugates
11/15/2007WO2007109080A3 Deuterated hepatitis c protease inhibitors
11/15/2007WO2007104646A3 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases
11/15/2007WO2007090579A3 Substituted quinolones iii
11/15/2007WO2007089906A3 Cationic steroid antimicrobial compositions for treating or preventing herpes infections
11/15/2007WO2007087758A3 Mimotopes of capsular polysaccharides of neisseria meningitidis and pharmaceutical formulations
11/15/2007WO2007079390A3 Medicament for topical use
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007067416A3 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
11/15/2007WO2007000043A3 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors
11/15/2007WO2006136162A3 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
11/15/2007WO2003106666A3 Protein c variants with altered properties
11/15/2007WO2002068586A3 Hiv/fiv protease inhibitors
11/15/2007US20070265451 Process for the preparation of oxazolidinones and method of use thereof
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265433 Process and Materials for the Rapid Detection of Streptococcus Pneumoniae Employing Purified Antigen-Specific Antibodies
11/15/2007US20070265352 Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
11/15/2007US20070265337 Method and composition for delivering zinc to the nasal membrane
11/15/2007US20070265335 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsufonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265319 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
11/15/2007US20070265295 1-Heterocyclyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones
11/15/2007US20070265294 Formulations and methods for vascular permeability-related diseases or conditions
11/15/2007US20070265293 Opioid antagonists; lyophilization
11/15/2007US20070265287 Method for Producing 2-Amino-4,6-Dichloro-5-Formamidopyrimidine
11/15/2007US20070265281 Organic Compounds and Their Uses
11/15/2007US20070265265 Such as 2-{4-[4-(Cyclopentanecarbonyl-amino)-phenyl]-thiazol-2-ylcarbamoyl}-pyrrolidine-1-carboxylic acid benzyl ester; Flaviviruses
11/15/2007US20070265264 Thia-tetraazaacenaphthylene kinase inhibitors
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265262 viricides selecting from a group of compounds, carbamoyl-pyrrolidine-1-carboxylic acid benzyl ester derivatives; treating or preventing a viral infection; 2-(2',4'-Dimethoxy-biphenyl-4-ylcarbamoyl)-pyrrolidine-1-carboxylic acid benzyl ester
11/15/2007US20070265242 Novel Carbapenem Compound
11/15/2007US20070265240 Sequence Selective Pyrrole and Imidazole Polyamide Metallocomplexes
11/15/2007US20070265227 Inhibition of hiv infection fhrough chemoprophyalxis
11/15/2007US20070265224 Nucleotide mimics and their prodrugs
11/15/2007US20070265222 Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
11/15/2007US20070265218 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
11/15/2007US20070265212 Drug Transport and Delivery System
11/15/2007US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007US20070265194 Agents for the treatment of viral infections
11/15/2007US20070265186 Biotin-Facilitated Transport in Gram Negative Bacteria
11/15/2007US20070264627 Retrovirus from the HIV group and its use
11/15/2007US20070264417 Procyanidins; cleaning cocoa beans, heating unroasted cocoa nibs to loosen shells, winnowing the nibs from the shells, extracting with a polar solvent, a non-polar solvent, or a supercritical fluid
11/15/2007US20070264359 administering an effective amount of an aqueous or alcohol extract of Phyllanthus to a mammal infected with the YMDD hepatitis B virus mutant strain resistant; inhibiting viral gene expression in a mammal infected with a hepatitis B virus
11/15/2007US20070264286 Tuberculosis Vaccines Including Recombinant BCG Strains Expressing Alanine Dehydrogenase, Serine Dehydratase and/or Glutamine Synthetase
11/15/2007US20070264285 Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof
11/15/2007US20070264283 Vaccine
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264271 Potent Immunostimulatory from Microalgae
11/15/2007US20070264264 Method and composition for conferring immunity in mammals
11/15/2007US20070264247 Use of Human Lysozyme in Preparation of Medicine for Treating Acne
11/15/2007US20070264235 Polypeptide Having an Improved Cytosine Deaminase Activity
11/15/2007US20070264233 Francisella Strain for Live Vaccine
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264196 Modulators of ATP-binding cassette transporters
11/15/2007DE102006020582A1 Verfahren zur Herstellung einer triterpensäurehaltigen wässrigen Lösung, triterpensäurehaltige wässrige Lösung und deren Verwendung A process for the preparation of a triterpenic acid aqueous solution containing triterpenic acid aqueous solution and the use thereof
11/15/2007CA2656780A1 Anti-viral pyrimidine nucleoside derivatives
11/15/2007CA2651239A1 Virus susceptibility by plant nucleosomes
11/15/2007CA2651232A1 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350
11/15/2007CA2651226A1 Pentacyclic indole derivatives as antiviral agents
11/15/2007CA2651225A1 Novel drugs for anti-herpes virus treatments
11/15/2007CA2650980A1 Statins for the treatment of viral influenza infections
11/15/2007CA2649962A1 Hcv coreceptor and methods of use thereof
11/15/2007CA2648831A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
11/14/2007EP1854886A2 Cold-adapted equine influenza viruses
11/14/2007EP1854469A1 Fermentation composition having immunomodulating effect
11/14/2007EP1853618A1 Tricyclic-nucleoside compounds for treating viral infections
11/14/2007EP1853617A1 Tricyclic-nucleoside prodrugs for treating viral infections
11/14/2007EP1853612A1 Purification of rapamycin
11/14/2007EP1853604A2 Chemical compounds
11/14/2007EP1853599A1 Novel polymorph of mutilin
11/14/2007EP1853587A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1853582A2 Heterocyclylamide-substituted imidazoles
11/14/2007EP1853573A1 Benzisothiazoles useful for treating or preventing hcv infection
11/14/2007EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007EP1853568A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives
11/14/2007EP1853567A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
11/14/2007EP1853317A2 Compositions and methods for treating or preventing flaviviridae infections
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853251A2 Boron-containing small molecules
11/14/2007EP1669379B1 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents
11/14/2007EP1654261B1 Hepatitis c inhibitor compounds
11/14/2007EP1581223B1 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1332145B1 Process for formulation of antibiotic compounds
11/14/2007EP1322666B1 Hiv peptides from tat,rev and wef conserved regions and their application as e.gvacine compnents
11/14/2007EP1317555B1 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses
11/14/2007EP1309860B1 Method for screening peptides for use in immunotherapy
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1254239B1 Mammalian secreted group iii phospholipase a2
11/14/2007EP1114156B1 Mammalian transforming growth factor beta - 9 (ztgfss9)
11/14/2007EP0990654B1 Substituted cyclobutylamine derivatives
11/14/2007EP0866654B1 Method for treating hepatitis virus infection
11/14/2007CN101072795A Human monoclonal antibodies to influenza m2 protein and methods of making and using same
11/14/2007CN101072793A Il-7 variants with reduced immunogenicity